Pyruvate enhances stallion sperm function in high glucose media improving overall metabolic efficiency
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved..
If a mechanism of more efficient glycolysis depending on pyruvate is present in stallion spermatozoa, detrimental effects of higher glucose concentrations that are common in current commercial extenders could be counteracted. To test this hypothesis, spermatozoa were incubated in a 67 mM Glucose modified Tyrode's media in the presence of 1- or 10-mM pyruvate and in the Tyrode's basal media which contains 5 mM glucose. Spermatozoa incubated for 3 h at 37 °C in 67 mM Tyrode's media with 10 mM pyruvate showed increased motility in comparison with aliquots incubated in Tyrode's 5 mM glucose and Tyrode's 67 mM glucose (57.1 ± 3.5 and 58.1 ± 1.9 to 73.0 ± 1.1 %; P < 0.01). Spermatozoa incubated in Tyrode's with 67 mM glucose 10 mM pyruvate maintained the viability along the incubation (64.03 ± 15.4 vs 61.3 ± 10.2), while spermatozoa incubated in 67 mM Glucose-Tyrode's showed a decrease in viability (38.01 ± 11.2, P < 0.01). 40 mM oxamate, an inhibitor of the lactate dehydrogenase LDH, reduced sperm viability (P < 0.05, from 76 ± 5 in 67 mM Glucose/10 mM pyruvate to 68.0 ± 4.3 %, P < 0.05). Apoptotic markers increased in the presence of oxamate. (P < 0.01). UHPLC/MS/MS showed that 10 mM pyruvate increased pyruvate, lactate, ATP and NAD+ while phosphoenolpyruvate decreased. The mechanisms that explain the improvement of in presence of 10 mM pyruvate involve the conversion of lactate to pyruvate and increased NAD+ enhancing the efficiency of the glycolysis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:215 |
|---|---|
| Enthalten in: |
Theriogenology - 215(2024) vom: 04. Jan., Seite 113-124 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Martín-Cano, Francisco E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
0U46U6E8UK |
|---|
| Anmerkungen: |
Date Completed 08.01.2024 Date Revised 08.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.theriogenology.2023.11.019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365208280 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365208280 | ||
| 003 | DE-627 | ||
| 005 | 20240114232037.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.theriogenology.2023.11.019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1252.xml |
| 035 | |a (DE-627)NLM365208280 | ||
| 035 | |a (NLM)38029686 | ||
| 035 | |a (PII)S0093-691X(23)00452-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martín-Cano, Francisco E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pyruvate enhances stallion sperm function in high glucose media improving overall metabolic efficiency |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.01.2024 | ||
| 500 | |a Date Revised 08.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a If a mechanism of more efficient glycolysis depending on pyruvate is present in stallion spermatozoa, detrimental effects of higher glucose concentrations that are common in current commercial extenders could be counteracted. To test this hypothesis, spermatozoa were incubated in a 67 mM Glucose modified Tyrode's media in the presence of 1- or 10-mM pyruvate and in the Tyrode's basal media which contains 5 mM glucose. Spermatozoa incubated for 3 h at 37 °C in 67 mM Tyrode's media with 10 mM pyruvate showed increased motility in comparison with aliquots incubated in Tyrode's 5 mM glucose and Tyrode's 67 mM glucose (57.1 ± 3.5 and 58.1 ± 1.9 to 73.0 ± 1.1 %; P < 0.01). Spermatozoa incubated in Tyrode's with 67 mM glucose 10 mM pyruvate maintained the viability along the incubation (64.03 ± 15.4 vs 61.3 ± 10.2), while spermatozoa incubated in 67 mM Glucose-Tyrode's showed a decrease in viability (38.01 ± 11.2, P < 0.01). 40 mM oxamate, an inhibitor of the lactate dehydrogenase LDH, reduced sperm viability (P < 0.05, from 76 ± 5 in 67 mM Glucose/10 mM pyruvate to 68.0 ± 4.3 %, P < 0.05). Apoptotic markers increased in the presence of oxamate. (P < 0.01). UHPLC/MS/MS showed that 10 mM pyruvate increased pyruvate, lactate, ATP and NAD+ while phosphoenolpyruvate decreased. The mechanisms that explain the improvement of in presence of 10 mM pyruvate involve the conversion of lactate to pyruvate and increased NAD+ enhancing the efficiency of the glycolysis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a CASA | |
| 650 | 4 | |a Flow cytometry | |
| 650 | 4 | |a Metabolomics | |
| 650 | 4 | |a Pyruvate | |
| 650 | 4 | |a Sperm | |
| 650 | 4 | |a Stallion | |
| 650 | 7 | |a Pyruvic Acid |2 NLM | |
| 650 | 7 | |a 8558G7RUTR |2 NLM | |
| 650 | 7 | |a NAD |2 NLM | |
| 650 | 7 | |a 0U46U6E8UK |2 NLM | |
| 650 | 7 | |a Lactates |2 NLM | |
| 650 | 7 | |a Glucose |2 NLM | |
| 650 | 7 | |a IY9XDZ35W2 |2 NLM | |
| 700 | 1 | |a Gaitskell-Phillips, Gemma |e verfasserin |4 aut | |
| 700 | 1 | |a Becerro-Rey, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a da Silva, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Masot, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Redondo, Eloy |e verfasserin |4 aut | |
| 700 | 1 | |a Silva-Rodríguez, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Ortega-Ferrusola, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Gil, María Cruz |e verfasserin |4 aut | |
| 700 | 1 | |a Peña, Fernando J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Theriogenology |d 1974 |g 215(2024) vom: 04. Jan., Seite 113-124 |w (DE-627)NLM00008154X |x 1879-3231 |7 nnns |
| 773 | 1 | 8 | |g volume:215 |g year:2024 |g day:04 |g month:01 |g pages:113-124 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.theriogenology.2023.11.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 215 |j 2024 |b 04 |c 01 |h 113-124 | ||